Global Circulating Tumor Cell Diagnostics Scope and Market Size
Circulating Tumor Cell Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
CTC Enrichment
CTC Detection
CTC Analysis
Market segment by Application, split into
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others
Based on regional and country-level analysis, the Circulating Tumor Cell Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Circulating Tumor Cell Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Tumorigenesis research
1.3.3 EMT biomarkers development
1.3.4 Cancer stem cell research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell Diagnostics Market Perspective (2015-2026)
2.2 Global Circulating Tumor Cell Diagnostics Growth Trends by Regions
2.2.1 Circulating Tumor Cell Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cell Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cell Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell Diagnostics Players by Market Size
3.1.1 Global Top Circulating Tumor Cell Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Circulating Tumor Cell Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell Diagnostics Revenue
3.4 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Diagnostics Revenue in 2019
3.5 Key Players Circulating Tumor Cell Diagnostics Area Served
3.6 Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Type (2021-2026)
5 Circulating Tumor Cell Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Tumor Cell Diagnostics Market Size (2015-2026)
6.2 North America Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
6.3 North America Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
6.4 North America Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Circulating Tumor Cell Diagnostics Market Size (2015-2026)
7.2 Europe Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
7.3 Europe Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
7.4 Europe Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Circulating Tumor Cell Diagnostics Market Size (2015-2026)
8.2 China Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
8.3 China Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
8.4 China Circulating Tumor Cell Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Circulating Tumor Cell Diagnostics Market Size (2015-2026)
9.2 Japan Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
9.3 Japan Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
9.4 Japan Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cell Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Circulating Tumor Cell Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Janssen Diagnostics
11.1.1 Janssen Diagnostics Company Details
11.1.2 Janssen Diagnostics Business Overview
11.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Introduction
11.1.4 Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020))
11.1.5 Janssen Diagnostics Recent Development
11.2 Advanced Cell Diagnostics
11.2.1 Advanced Cell Diagnostics Company Details
11.2.2 Advanced Cell Diagnostics Business Overview
11.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Introduction
11.2.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.2.5 Advanced Cell Diagnostics Recent Development
11.3 Aviva Biosciences
11.3.1 Aviva Biosciences Company Details
11.3.2 Aviva Biosciences Business Overview
11.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Introduction
11.3.4 Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.3.5 Aviva Biosciences Recent Development
11.4 Biocept Inc
11.4.1 Biocept Inc Company Details
11.4.2 Biocept Inc Business Overview
11.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Introduction
11.4.4 Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.4.5 Biocept Inc Recent Development
11.5 Biofluidica Inc.
11.5.1 Biofluidica Inc. Company Details
11.5.2 Biofluidica Inc. Business Overview
11.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Introduction
11.5.4 Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.5.5 Biofluidica Inc. Recent Development
11.6 CellTraffix Inc.
11.6.1 CellTraffix Inc. Company Details
11.6.2 CellTraffix Inc. Business Overview
11.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Introduction
11.6.4 CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.6.5 CellTraffix Inc. Recent Development
11.7 Clearbridge BioMedics Pte Ltd
11.7.1 Clearbridge BioMedics Pte Ltd Company Details
11.7.2 Clearbridge BioMedics Pte Ltd Business Overview
11.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Introduction
11.7.4 Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.7.5 Clearbridge BioMedics Pte Ltd Recent Development
11.8 Epic Sciences Inc.
11.8.1 Epic Sciences Inc. Company Details
11.8.2 Epic Sciences Inc. Business Overview
11.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Introduction
11.8.4 Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.8.5 Epic Sciences Inc. Recent Development
11.9 Fluxion Biosciences Inc.
11.9.1 Fluxion Biosciences Inc. Company Details
11.9.2 Fluxion Biosciences Inc. Business Overview
11.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Introduction
11.9.4 Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.9.5 Fluxion Biosciences Inc. Recent Development
11.10 ScreenCell
11.10.1 ScreenCell Company Details
11.10.2 ScreenCell Business Overview
11.10.3 ScreenCell Circulating Tumor Cell Diagnostics Introduction
11.10.4 ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
11.10.5 ScreenCell Recent Development
11.11 Silicon Biosystems
10.11.1 Silicon Biosystems Company Details
10.11.2 Silicon Biosystems Business Overview
10.11.3 Silicon Biosystems Circulating Tumor Cell Diagnostics Introduction
10.11.4 Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.11.5 Silicon Biosystems Recent Development
11.12 Sysmex Corporation
10.12.1 Sysmex Corporation Company Details
10.12.2 Sysmex Corporation Business Overview
10.12.3 Sysmex Corporation Circulating Tumor Cell Diagnostics Introduction
10.12.4 Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.12.5 Sysmex Corporation Recent Development
11.13 Greiner Bio-One GmbH
10.13.1 Greiner Bio-One GmbH Company Details
10.13.2 Greiner Bio-One GmbH Business Overview
10.13.3 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Introduction
10.13.4 Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.13.5 Greiner Bio-One GmbH Recent Development
11.14 AdnaGen AG
10.14.1 AdnaGen AG Company Details
10.14.2 AdnaGen AG Business Overview
10.14.3 AdnaGen AG Circulating Tumor Cell Diagnostics Introduction
10.14.4 AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.14.5 AdnaGen AG Recent Development
11.15 Apocell Inc
10.15.1 Apocell Inc Company Details
10.15.2 Apocell Inc Business Overview
10.15.3 Apocell Inc Circulating Tumor Cell Diagnostics Introduction
10.15.4 Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.15.5 Apocell Inc Recent Development
11.16 Biocep Ltd
10.16.1 Biocep Ltd Company Details
10.16.2 Biocep Ltd Business Overview
10.16.3 Biocep Ltd Circulating Tumor Cell Diagnostics Introduction
10.16.4 Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.16.5 Biocep Ltd Recent Development
11.17 Canopus Bioscience Ltd
10.17.1 Canopus Bioscience Ltd Company Details
10.17.2 Canopus Bioscience Ltd Business Overview
10.17.3 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Introduction
10.17.4 Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.17.5 Canopus Bioscience Ltd Recent Development
11.18 Creatv Microtech Inc
10.18.1 Creatv Microtech Inc Company Details
10.18.2 Creatv Microtech Inc Business Overview
10.18.3 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Introduction
10.18.4 Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.18.5 Creatv Microtech Inc Recent Development
11.19 Ikonisys Inc
10.19.1 Ikonisys Inc Company Details
10.19.2 Ikonisys Inc Business Overview
10.19.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Introduction
10.19.4 Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.19.5 Ikonisys Inc Recent Development
11.20 IV Diagnostics Inc
10.20.1 IV Diagnostics Inc Company Details
10.20.2 IV Diagnostics Inc Business Overview
10.20.3 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Introduction
10.20.4 IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.20.5 IV Diagnostics Inc Recent Development
11.21 Miltenyi Biotech GmbH
10.21.1 Miltenyi Biotech GmbH Company Details
10.21.2 Miltenyi Biotech GmbH Business Overview
10.21.3 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Introduction
10.21.4 Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.21.5 Miltenyi Biotech GmbH Recent Development
11.22 Nanostring Technologies Inc
10.22.1 Nanostring Technologies Inc Company Details
10.22.2 Nanostring Technologies Inc Business Overview
10.22.3 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Introduction
10.22.4 Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.22.5 Nanostring Technologies Inc Recent Development
11.23 Rarecells Diagnostics.
10.23.1 Rarecells Diagnostics. Company Details
10.23.2 Rarecells Diagnostics. Business Overview
10.23.3 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Introduction
10.23.4 Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.23.5 Rarecells Diagnostics. Recent Development
11.24 Vitatex Inc
10.24.1 Vitatex Inc Company Details
10.24.2 Vitatex Inc Business Overview
10.24.3 Vitatex Inc Circulating Tumor Cell Diagnostics Introduction
10.24.4 Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2015-2020)
10.24.5 Vitatex Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc
*If Applicable.